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Our previous cytogenetic studies on murine T  cell leukemias and plasmacyto- 
mas have suggested that gene(s) located in the distal segment of chromosome 15 
are involved in the genesis of these malignancies (1-5). This segment tended to 
duplicate during T  cell leukemogenesis, whereas in plasmacytomas it was trans- 
posed to chromosome 12 or 6 (6, 7), known to carry the Ig heavy chain and the 
kappa light chain locus, respectively (8). 
Leukemias induced in heterozygous F1 mice with cytogenetically distinguish- 
able  chromosomes  No.  15  showed  an  asymmetry  of the  leukemia-associated 
duplication  pattern;  i.e.,  one of the two parental  15 chromosomes was prefer- 
entiaily  duplicated  (9-11).  This  preference  showed  a  consistent  "hierarchy" 
between  different  mouse  strains.  Since  the  two  complementary  products  of 
nondisjunction are generated with the same frequency, the likelihood of leukemia 
development  must  be  different,  depending  on  the  strain  derivation  of  the 
duplicated 15 chromosome. We have taken this to suggest that the gene involved 
in leukemia development, or its regulatory element,  is subject to genetic varia- 
tion. 
On the basis of these cytogenetic studies, we have suggested that the segment 
of chromosome 15 distal to band D2/3 carries an oncogene that plays an essential 
role in the genesis of these tumors.  Viral promoter insertion and/or regulation 
mutation appeared as the more likely mechanisms of oncogene activation for the 
T  cell lymphomas. The chromosome that carried the activated gene would need 
to be duplicated to overcome a trans-acting regulatory influence emanating from 
the normal homologue. Somatic hybrid studies gave positive evidence for a trans- 
acting control of this type (12). 
We have also suggested that the activation of the same oncogene is responsible 
for  the  genesis  of the  murine  plasmacytomas  (7).  Transposition  of the  same 
chromosome segment to a  functionally active Ig gene region would lead to the 
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switch of the oncogene in this cell (13). 
Recent molecular studies confirmed some of these ideas (reviewed in reference 
14).  They  showed  that  a  cellular  oncogene,  c-myc, is  localized  on  the  distal 
segment  of chromosome  15,  in  the  immediate  vicinity  of the  translocation 
breakpoint.  In the plasmacytomas, it is transposed into the Ig gene area.  In the 
majority of the 12; 15 transiocations so far studied, c-myc was found to rearrange 
to the S region of the IgH gene. 
Plasmacytomas  are  highly  differentiated  B  cell  tumors  that  can  be  readily 
induced in BALB/c and N ZB mice (15, 16). The specific t(12; 15) and rcpt(6; 15) 
translocation chromosomes are regularly present,  irrespectively of the mode of 
induction.  Unrelated mouse strains and various BALB/c FI outcross hybrids are 
usually much less susceptible to plasmacytoma induction. 
In the present study, we have asked the question whether the high susceptibility 
of the BALB/c strain to plasmacytoma induction is linked to some peculiarity of 
the  c-myc-carrying  region  of chromosome  15.  If so,  one  might  expect  that 
plasmacytomas induced in F1 hybrids derived from the cross of BALB/c with a 
more resistant strain would show a preferential transposition of the distal segment 
of the BALB/c-derived chromosome 15 to chromosome 12 or 6, in comparison 
with the corresponding chromosome segment derived from the more resistant 
strain.  This  was  examined  for  the  AKR(6;15)  x  BALB/c  cross  where  the 
chromosomes  15  of the  two  parental  strains  could  be  cytogeneticaUy distin- 
guished.  We found no significant preference for the BALB/c-derived chromo- 
some  15  although  it  served  somewhat  more  frequently  as  the  donor  of the 
transposed segment than its AKR-derived counterpart. As a byproduct, we have 
discovered three tumors where the plasmacytoma-associated variant 6;15 trans- 
location  arose  by the  pericentric  inversion  of the  AKR-derived  Robertsonian 
6; 15 chromosome, i.e., by an exchange within a single chromosomal element. 
Materials and Methods 
AKR(6;15) Mice.  The Rb(6;15)  I Ald translocation  was observed in  1966, in a small 
inbreeding stock of AKR mice (17). This strain  of mice is syngeneic to the AKR/J (The 
Jackson Laboratory, Bar Harbor, ME) from which it originated in 1961. 
Plasmacytoma Induction.  AKR(6;15) mice were crossed with BALB/c to produce an F2 
population. Spleen or peripheral blood lymphocytes from these mice were cultured and 
examined cytologically for Rb 6; 15 chromosomes.  One male carrying Rb 6; 15/Rb 6; 15 
was identified and mated to BALB/c females to raise a backcross population of the genetic 
constitution  Rb 6;15/6;15.  Plasmacytomas  were  induced  in  these  mice  by three  i.p. 
injections of 0.5 ml pristane (2,6,10,14-tetramethyl pentadecane; Aldrich  Chemical Co., 
Milwaukee, WI). 
Of 60 mice, 28 developed plasmacytomas in the first year. Morphologically, the tumors 
were typical plasmacytomas  and were transplanted  to pristane-conditioned (BALB/c X 
AKR 6; 15)FI mice. The heavy chain  classes of these tumors secrete IgG and IgA type 
myeloma proteins. The tumors were cytologically typed in the original  mouse or in the 
first generation transplant recipient. 
Chromosome Preparation.  Metaphase  plates were prepared from the ascitic form of the 
plasmacytomas,  without colcemid treatment. Banding was performed by a slight modifi- 
cation of Wang and Fedoroff's method (18). Chromosomes were identified according to 
the Standard Mouse Karyotype (19). 
Breakpoint Analysis.  Breakpoints were determined by high resolution banding accord- 
ing to the method of Rybak et al. (20). Sub-band localization followed the nomenclature 
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Results 
Table I summarizes the passage history, chromosome constitution, and trans- 
location type of the plasmacytomas analyzed. Table II shows the results of the 
G-banding analysis. A  total of 101  plates were karyotyped and analyzed, 7-12 
plates per tumor. Possible alternatives are illustrated schematically in Fig.  I, A- 
E. We have actually found six tumors that carried translocations corresponding 
to alternative A,  one  with B,  none  with C  or D,  and  three  with an  originally 
unexpected pericentric inversion, included in Fig. 1 as alternative E. Back to our 
original question, as far as the strain derivation of chromosome 15 is concerned, 
this  means  that  the  tumors  fall  into  the  following  two  groups:  (a)  The  six 
plasmacytomas that  behaved  according  to alternative A  contained  the  typical 
t(12;15)  translocation, with the BALB/c-derived chromosome  15 as the donor 
of the  transposed  segment (Fig.  2).  (b)  In  the  four  remaining plasmacytomas 
CAKTepc 2002  (alternative B),  CAKTepc  1198,  1199,  and  2014  (alternative 
E), the distal part of the AKR-derived chromosome 15 (part of the Robertsonian 
6;15  fusion  chromosome)  was  translocated.  In  CAKTepc  2002,  it  moved  to 
chromosome  12 (Fig. 3), generating a  typical t(12; 15) translocation. CAKTepc 
TABLE  I 
Passage History, Chromosome Constitution, and Translocation Pattern of the Plasmacytomas 
Induced in (BALB/c × AKR 6;15) X BALB/c Backcross Mice 
Passage  Modal  No. of kar-  Type of transloca-  Alterna- 
Plasmacytoma  genera-  chromo-  yotyped  tion  tive in 
tion  some no.  plates  Fig.  ! 
CAKTEPC 1192  2  58  7  t(12;15)  A 
1198  6  49  11  inv(Rb 6;15)  E 
1199  4  72  11  inv(Rb 6;15)  E 
2000  6  80  12  t(12;15)  A 
2002  5  72  10  t(12;15)  B 
2003  5  74  9  t(12;15)  A 
2004  2  65  7  t(12;15)  A 
2005  3  91  10  t(12;15)  A 
2006  2  71  12  t(12;15)  A 
2014  6  68  12  inv(Rb 6;15)  E 
Tumor 
TABLE  II 
Mean Chromosome Number per Total Analyzed Plates 
Transplant  No. of 
generation  plates 
Chromosome 
CAKTepc 1192  2  7  3.0  3.2  3.2  3.2  3.0  2,0  2.8  2.2  3.2  3.0  3.2  1.2  1.8  1.8 
CAKTepc 1198  6  11  2.5  2.4  2.5  1.6  2.5  1.3  2.3  2.5  2.5  2.5  2.5  2.5  2.4  2.5 
CAKTepc 1199  4  11  4.2  3.6  4.2  4,1  3.8  2,0  3.4  3,5  2.9  4.1  3.4  1.9  3.1  0.9 
CAKTepc 2000  6  12  3.8  4.3  4.0  4.0  3,0  2.0  3.8  3.0  3.9  3.8  3.1  1,9  3.7  3.3 
CAKTepc 2002  5  10  5.6  4.0  4,0  4.0  4.0  4.0  3.6  3.0  4.0  4.0  5.3  2.0  3.6  3.3 
CAKTepc 2003  5  9  3.7  3.7  3.8  3.1  3~2  2.0  3.3  3,1  3.6  4.0  4.4  1.8  3.5  3.8 
CAKTepc 2004  2  7  4.7  3.8  4.0  4.0  3.1  2.0  3.4  3.7  4.0  4.0  4.5  2.0  3.2  3.0 
CAKTepc 2005  3  I0  4,0  3.0  3.5  3.7  3.0  1.7  3.2  3.2  3.2  3.0  4,5  1.5  3.2  2.7 
CAKTepc 2006  2  12  .5.8  4.8  4.0  3.8  3.8  2.0  3.9  3.9  4.0  4.9  4.9  1.9  4.0  3.8 
CAKTepc 2014  6  12  3.9  3.2  4.0  4.0  4.0  2.0  3.7  3.2  2.4  3.7  4.1  2.1  2.3  0.5 
1  2  3  4  5  6  7  8  9  10  11  12  13  14 WIENER  ET  AL.  279 
1198,  1199,  and  2014  showed  a  very  different  and  previously  unidentified 
pattern.  A  variant  translocation  of the  rcpt(6;15)  type  was  generated  by  two 
breaks in the single AKR-derived  Rb 6; 15 chromosome, with pericentric inver- 
sion as the result (Fig. 4). Since this extraordinary reciprocal translocation that 
affected the two distal ends of a single  Robertsonian chromosome appeared  in 
three  different  tumors,  contamination  had  to  be  excluded.  This  was  readily 
achieved by the detailed cytogenetic analysis.  As shown in Table II, CAKTepc 
1198 has a marker chromosome in all plates analyzed. One of the chromosomes 
No.  4  was  elongated,  possibly  due  to  an  interstitial  duplication  (Fig.  4).  In 
CAKTepc  1199  this  marker  chromosome  was  absent;  this  tumor  contained 
BALB/C  BALB/C  AKR 
J 
PC-INDUCTION 
A  B 
inv 
C  D  E  6;15 
rc-p  inv 
15;6 
FIGURE  1.  Chromosome  constitution of normal  mouse derived from the (BALB/c  X  AKR 
6; 15) X  BALB/c  backcross (top row). Possible translocation patterns ofplasmacytomas induced 
in (BALB/c  X  AKR  6;15) X  BALB/c  backcross mice. 
numbers 
15  16  17  18  19  X  Rb6;15  6;15q-  Inv, 6;15  12q+  15q-  14q-  4q+  Marker  Chr.  Rb 11;11 
1.0  3,0  2.6  2.8  2.8  2.8  1.4  1.8  1.4  1.0 
1.2  2.4  2.5  2.3  2.5  2.5  1.3  0.9 
2.0  3.7  4.1  3.7  4.0  2,9  2.0  2,0  2.0 
O.0  3,6  3.7  4.0  3.3  2.1  2.0  2.0  2.0  1.0 
2.0  4.6  3.6  4.0  3.6  3.3  1.0  1.0  2.0  1.0 
0.5  3.7  3.6  3.6  3.4  3.7  1.8  2.0  2.0  0.8 
0.0  4.7  3.4  3.8  3.1  3.8  2.0  2.0  2.0 
0.2  3.0  3.0  2.5  3.0  3.2  2.0  2.5  1.25 
0.0  4.7  2.9  3,9  3.8  3.9  2.0  2.9  1.9 
1.9  4.0  3.4  3.3  3.8  2.1  1.9  2.0  1.9  0,8 
0.7 
Total 
Chr. No. 
58.2 
49.0 
72.2 
71.1 
80.0 
72.0 
74.0 
64.5 
91.0 
68.2 >
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FIGURE 4.  G-banded  karyotype  of the  near-diploid  plasmacytoma  CAKTepc  1198.  The 
AKR-derived  Rb  6;15  chromosome  has  undergone  pericentric  inversion,  leading  to  an 
rcpt(6;15)  translocation  (details in Fig. 7).  The BALB/c-derived chromosomes 6 and  15 are 
intact  (corresponds  to  alternative E  of Fig.  1).  Note the  interstitial  duplication  in  one  of 
chromosome 4. WIENER  ET  AL.  283 
1 2  rcp t(12;15)  rcpt(15;12)  15 
FIGURE 5.  High resolution banding of the chromosomes involved in a t(12; 15) translocation. 
Note that the F2 band of chromosome 12 is translocated onto the band D2/3 of chromosome 
15. The breakpoint affects band Fl on chromosome 12. The translocation is reciprocal. 284  BANDING  ANALYSIS  OF  PLASMACYTOMA  TRANSLOCATIONS 
6  rcpt(6;15)  rcpt(15;6)  15 
FIGURE 6.  High resolution banding of the chromosomes involved in the rcpt(6;l 5) translo- 
cation in plasmacytomas ABPC-4 (Ohno et al., submitted  for publication).  The breakpoints 
are at D2/3 on chromosome 15 and C2 on chromosome 6. WIENER  ET  AL.  285 
FIGURr  7.  High resolution banding of the rcpt(6;15) translocation generated by the pericen- 
tric inversion of the AKR-derived Rb(6;15) chromosome in CAKTepc  1198 plasmacytoma. 
This translocation arose by two breaks of the chromosome arms on each side of the centromere. 
Note the identity of the breakpoints with those involved in the usual rcpt(6;15) translocation 
(Fig. 6). 286  BANDING  ANALYSIS  OF  PLASMACYTOMA  TRANSLOCATIONS 
another marker, generated by a translocation between chromosomes 12 and 14, 
i.e., t(12;14).  Interestingly enough, in CAKTepc 2014  both inv(Rb, 6;15) and 
the t(12; 14) chromosomes were present, similarly to those found in CAKTepc 
1199. 
Breakpoint Analysis.  In our previous studies (6, 7) we have attempted to define 
the breakpoints on chromosomes 6,  12, and 15 by conventional G-banding. The 
limits of the technique did not permit an accurate definition, however. It was 
also unclear whether the t(12; 15) rearrangement was reciprocal or of the deletion 
type. By using a high resolution banding (HRB) technique we could now settle 
this issue and determine the breakpoints more exactly. 
The HRB analysis confirmed the reciprocal nature of the t(12;15) transloca- 
tion. The breakpoint was located between bands  D2 and D3  (D2/3)  on chro- 
mosome 15 and within band F1 on chromosome 12. The F2 band of chromosome 
12 was translocated onto D2/3 of chromosome 15 (Fig. 5). The rearrangement 
should be designated as rcpt(12; 15). 
The breakpoints on  the rcpt(6;15)  translocation were presently analyzed in 
the plasmacytoma ABPC-4  (Ohno,  S.,  S.  Migita,  F.  Wiener,  M.  Babonits,  G. 
Klein,  F.  Mushinski,  and  M.  Potter.  Cytogenetic  studies  on  plasmacytomas 
induced in BALB/c mice by pristane and Abelson virus. Submitted for publica- 
tion) in order to facilitate comparison with the pericentric inversion observed in 
the CAKTepc 1198,  1199, and 2014 tumors of the present series. HRB analysis 
confirmed our previous conclusion from conventional G-banding.  The break- 
point on chromosome 15 was within bands D2/3 and on chromosome 6 in band 
C2 (Fig. 6). 
HRB analysis of the inv (Rb 6;15) chromosomes in tumors CAKTecp 1198, 
1199, and 2014 was of particularly great interest. It showed that the breakpoints 
were the same as in  the usual rcpt(6;15) that arises by a  reciprocal exchange 
between two independent chromosomes, namely bands D2/3  on chromosome 
15 and C2 on chromosome 6 (Fig. 7). 
Discussion 
Chromosome 15 is regularly involved in the nonrandom chromosomal changes 
that occur most frequently in murine T  cell lymphomas and in plasmacytomas. 
Trisomy, due to the duplication of one chromosome 15 is the most regular and 
often the single chromosome change seen in the T  cell lymphomas, irrespective 
of their mode of induction (22). Studies on mice with reciprocal translocations 
have shown that the important segment that tends to become duplicated in the 
course of leukemogenesis is localized in the distal part of chromosome 15 (3, 5). 
In plasmacytomas, the same distal segment is translocated to the Ig heavy chain 
locus carrying chromosome 12 or to the kappa gene-carrying chromosome 6 (6, 
7). 
AKR mice develop spontaneous T cell leukemias with great frequency. Several 
genes contribute to  this process, including two or  more integrated ecotropic 
proviral genes Akv-1  and 2, a  viral amplification gene (Fv-1), and a  gene that 
renders the mice immunologically unresponsive to the leukemic cells (Rgv-lS). 
In addition,  AKR  mice also  carry gene(s) that  increase the likelihood of the WIENER  ET  AL.  287 
neoplastic transformation at the level of the target T  cell itself. 
We have previously found that the AKR-derived chromosome 15 duplicates 
preferentially in trisomic leukemias induced in F1 hybrid mice, to the complete 
exclusion of the chromosome 15 of the other genetically unrelated parent (9- 
11). Since the frequency of the two complementary trisomic types generated by 
nondisjunction must be equal, this must mean that the duplication of the AKR- 
derived chromosome 15  renders the target T  cell more leukemia-prone than 
,]oes the duplication of its partner. 
The BALB/c strain has an extraordinary susceptibility to plasmacytoma induc- 
ion by the intraperitoneal administration of mineral oil or by other means (15, 
16). The BALB/c genes and gene products responsible for the susceptibility are 
presently unknown.  Since the distal  region of chromosome  15  is  involved in 
plasmacytoma genesis, we wanted to examine the question whether the plasma- 
cytoma-associated  12;15  or  6;15  translocation  would  preferentially  use  the 
BALB/c-derived chromosome No.  15, when in competition with chromosome 
15  from another, plasmacytoma-resistant strain.  When AKR mice are injected 
with  pristane,  most  animals  develop  thymic  leukemias,  preventing  a  direct 
assessment of their plasmacytoma susceptibility. (BALB/c x  AKR)FI mice appear 
to be resistant to plasmacytoma development, however (M. Potter and J. S. Wax, 
unpublished observations). 
As a first step towards a more extensive study, we have introduced the AKR- 
derived chromosome No.  15  onto the background of the BALB/c strain.  We 
could exploit the availability of a Robertsonian 6; 15 fusion chromosome that has 
arisen in the AKR strain (17) and is easily distinguishable from the normal  15 
chromosome of BALB/c. 
The cytogenetic analysis of 10 tumors induced in backcross mice heterozygous 
for the AKR-derived 6; 15 and the BALB/c-derived 15 chromosome have iden- 
tified the BALB/c chromosome as the translocation donor in six of the tumors, 
whereas the AKR-derived  15  chromosome served in the same capacity in the 
remaining four. Although larger numbers of tumors need to be examined, this 
material already indicates that chromosome 15 originating from these two strains 
participate in the tumor-associated translocation at random. This conclusion is 
further supported by our current experiments on another cross, where the CBA 
T6T6-derived t(14;15)  chromosome was introduced on BALB/c background. 
CBA  T6T6  and  (BALB/c  X  CBA  T6T6)F1  mice are resistant to  developing 
plasmacytomas (M. Potter and J. S. Wax, unpublished observations). So far, we 
have examined two plasmacytomas induced in the t(14;15) mice with a largely 
BALB/c background. Both carried the typical  12;15  translocation. It arose by 
the transposition of the distal segment of the CBA T6T6-derived 14;15  chro- 
mosome in both cases. 
The lack of any demonstrable strain preference in the plasmacytoma-associated 
translocation, in contrast to the duplication asymmetry observed in the course 
of T  cell leukemogenesis suggests that different mechanisms may be responsible 
for the development of these tumors.  In plasmacytomas, the oncogene c-myc, 
localized at  the  translocation  breakpoint  on  chromosome  15,  was  shown  to 
rearrange to the immediate vicinity of an Ig locus (23-26).  In plasmacytomas 
carrying the typical  12;15  translocation,  the rearrangement is  often (but  not 288  BANDING  ANALYSIS  OF  PLASMACYTOMA  TRANSLOCATIONS 
always) to the S alpha region of the IgH complex. This insertion of c-myc into a 
functionally active chromosome region and/or the scission of its 5' end, presumed 
to carry regulatory elements of  the gene, has been thought of as being responsible 
for the activation and/or abnormal transcription of the oncogene and subsequent 
neoplastic development (27). 
If this  is  the correct scenario, it  must also follow that the homologous un- 
changed chromosomes Nos. 15 and 12 do not exert any regulatory or suppressive 
influence on  the expression of the tumorigenic phenotype.  Unlike the T  cell 
leukemia system, there is no chromosome amplification (trisomy). In the near- 
diploid plasmacytomas, the translocation chromosome and its normal homologue 
are present in a  single copy each. In tetraploid plasmacytomas the ratio is 2:2, 
suggesting that the translocation occurs before the tetraploidization of the tumor. 
Since the primary tumor is already often tetraploid,  this further supports our 
view that the translocation occurs in direct relationship to the tumorigenic event. 
This  is also in  line with  the fact that  the translocations are already found in 
primary (0 generation) tumors. 
In the 15-trisomic T  cell leukemias the situation is quite different. The very 
fact that only one of the two chromosomes No.  15 needs to be duplicated during 
leukemogenesis suggests an interplay between a changed gene and its regulators 
on  the  unchanged chromosome. We  have previously suggested (22)  that  the 
function of the  15 duplication is to overcome its regulation either by a dosage 
effect at  the gene or transcript  level,  or at  the  level of the protein  product. 
Somatic hybrid studies have given experimental evidence confirming the exist- 
ence of the postulated trans-acting control, by showing the regular amplification 
of the AKR leukemia-derived chromosome 15  and a  concomitant decrease in 
the number of its normal CBA fibroblasts-derived homologues, in high tumori- 
genic but not in low tumorigenic hybrids (12). The duplication preference of the 
AKR-derived 15 chromosome in the trisomic F~ hybrid leukemias--and the lack 
of a similar preference in the plasmacytoma system--may be understood against 
this background.  If the presumed oncogene is activated by proviral promoter 
insertion or by regular mutation during T  cell leukemogenesis, the likelihood of 
this event may differ greatly for 15-chromosomes different strains; selection of 
the AKR  mouse for  high  leukemia incidence may have  greatly increased its 
probability.  In contrast, plasmacytomagenesis brings the c-myc oncogene under 
the direct influence of a  highly active chromosome region. It is likely that the 
oncogene is activated constitutively by the cis-acting influence of an enhancer or 
a cryptic promoter in which case the strain origin of the oncogene itself may not 
matter. 
It is also conceivable that BALB/c mice carry a non-chromosome 15-associated 
gene whose product may increase the likelihood of chromosome translocations, 
whereas the corresponding AKR gene would not have such an effect. Hence, 
there would be no strain difference between the  15 chromosomes of different 
origins,  even though  the two strains  might differ by a  non-chromosome 15- 
linked gene that could account for the difference in their plasmacytoma suscep- 
tibility. 
A  number of other findings have been made in the course of this study that 
deserve special mention. The apparently identical chromosome change observed WIENER  ET  AL.  289 
in the CAKTepc 1198,  1199, and 2014 plasmacytomas is particularly notewor- 
thy. In all three tumors, the AKR-derived Robertsonian (6;15) fusion chromo- 
some  has  been  solely  responsible  for  the  plasmacytoma-associated reciprocal 
translocation by exchanging its two terminal segments. The biarmed chromo- 
some has undergone a pericentric inversion, leading to the same type of trans- 
position and with the same breakpoints as previously observed in the "variant" 
BALB/c  plasmacytomas where two  separate,  normal  6  and  15  chromosomes 
participated in  the exchange. The fact that this can occur even in a  situation 
where the two chromosomes are fused with each other gives added weight to 
the importance of the translocations for plasmacytomagenesis. 
Summary 
Plasmacytomas were induced in (BALB/c x  AKR 6;15) x  BALB/c backcross 
mice where one of the BALB/c-derived chromosomes No.  15 was replaced by 
the  AKR(6;15)-derived  Robertsonian  6;15  chromosome.  (BALB/c  X  AKR 
6;15)F2 mice that were homozygous for Rb 6;15 were mated to BALB/c mice. 
Plasmacytomas were  induced  in  the  progeny  by  intraperitoneal  injection  of 
pristane. The cytogenetic marker permitted the distinctive identification of the 
two chromosome 15  homologues, including the distal segment involved in the 
plasmacytoma-specific translocations.  7  of the  10 plasmacytomas contained the 
typical t(12; 15)  translocation. The BALB/c-derived  15  chromosome served as 
the donor of the translocated segment in six  of them. In the seventh, the Rb 
6; 15 chromosome of the AKR strain was the donor. The remaining three tumors 
contained the same type of intrachromosomal rearrangement. It arose by the 
pericentric inversion of the Rb 6;15 chromosome, leading to a variant plasma- 
cytoma-associated rcpt(6;15)  translocation.  Unlike the usual  6;15  variant that 
arises  by  a  reciprocal  exchange  between  two  separate  chromosomes,  it  was 
generated  by  an  exchange  of the  distal  segments  of a  single  chromosomal 
element. High resolution banding analysis of the tumors showed that all trans- 
located  breakpoints  on  chromosomes  15,  12,  and  6  were  identical  with  the 
previously described  breakpoints  characteristic for  the typical  12;15  and  the 
variant 6; 15 translocation in murine plasmacytomas. 
It  is  known  that  the  distal  segment  of chromosome  15  carries  the  c-myc 
oncogene (23). The PC-associated translocations cut across the 5'-exon of c-myc 
in the majority of the cases (24, 26). The severed oncogene is transposed to the 
Ig-region  on  the  recipient  chromosome.  Since  the  BALB/c  strain  is  highly 
sensitive to PC-induction, we were interested to examine the question whether 
its  chromosome  15  is  preferred as  the  oncogene donor  in  AKR  ×  BALB/c 
backcross mice that carry cytogenetically distinguishable 15 chromosomes. Our 
results show that this is not the case, since the same segment of the AKR-derived 
chromosome 15 could also serve in the same capacity. This is in contrast with T 
cell  leukemogenesis where we  have  previously found  that  the  trisomization- 
associated  duplication  of chromosome  15  occurred in  a  highly asymmetrical 
fashion, depending on the donor strain of No.  15 (9-11). 
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